6/25/2025 Categories: Industries Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise
5/8/2026 Categories: Pharma Angelini Pharma to acquire Catalyst Pharmaceuticals, entering the U.S. Market and consolidating its leadership in Brain Health and Rare Disease
2/26/2026 Angelini Academy and IE Business School join forces to develop talent through the Angelini Academy Gateway
7/16/2025 Categories: Health Amuchina and Infasil: agreement reached for the transfer of the brands from Angelini Pharma to Fater
6/25/2025 Categories: Industries Angelini Industries: in 2024 net income up 30% to € 156 million. Group revenues (+3%) and EBITDA (+17%) also on the rise
6/19/2025 Categories: Industries Angelini Holding: Francesco Bianco appointed Group Chief Human Resources Officer
4/10/2025 Categories: Industries Thanks to Fondazione Angelini over 2,000 free tickets for Roman high school students to attend Syracuse's 60th season of Greek theater
Angelini Industries
